A new study, supported by AstraZeneca, has shown that a single dose of benralizumab significantly reduces treatment failure ...
The metastatic non-small cell lung cancer (mNSCLC) treatment landscape has vastly expanded over the past two decades as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback